Attention-deficit/hyperactivity disorder (ADHD) is characterized by a continuum of symptoms, including inattentiveness, impulsiveness, and hyperactivity, which can negatively impact daily life. In ...
It is important for children with ADHD and their families to learn about the medical basis of the condition, associated risks (e.g., comorbid mental health conditions, poor self-esteem, increased ...
Patients who meet the inattentive criteria but not the hyperactive criteria have inattentive-predominant ADHD, whereas those with more hyperactive-impulsive symptoms and fewer inattentive symptoms are ...
Attention Deficit Hyperactivity Disorder (ADHD) is an increasingly common diagnosis amongst children and young adults. In ...
For years, adults seeking treatment for attention deficit hyperactivity disorder (ADHD) in New Zealand have faced a frustrating bottleneck. Public mental health services have had little capacity to ...
Alkermes plc announced positive topline results from a phase 1 proof-of-concept study evaluating ALKS 7290, the company's novel, investigational orexin 2 receptor (OX2R) agonist in development for the ...
Alkermes plc (Nasdaq: ALKS) today announced positive topline results from a phase 1 proof-of-concept study evaluating ALKS 7290, the company’s novel, investigational orexin 2 receptor (OX2R) agonist ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results